Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

Massachusetts Attorney General Andrea Joy Campbell is suing UnitedHealth Group’s insurance subsidiary, UnitedHealthcare, alleging the company intentionally made low-income older adults appear sicker ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Jamie Justice of XPRIZE Healthspan on the most promising research and "purely scammy" treatments in the world of longevity.

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The Trump administration has released a sweeping proposal to overhaul ...

As Ebola outbreak grows, the U.S. retreats from the global health leadership. Any Americans who contract Ebola will not be brought to the United States for treatment, Trump admini ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

For Wall Street, the political risk of investing in drug companies has been demoted in comparison to other concerns ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

Kuppalli is an infectious diseases physician in Dallas. As the FIFA World Cup approaches, speculation on social media and cable news has already begun: Could Ebola spread at the tournament? The short ...

This week on "The Readout LOUD," longtime biotech exec Jeremy Levin talks about his new book and the industry's strategic turning point. Listen now.